SKYRIZI® Resources for Patient Access & Support
Find resources like the SKYRIZI® Complete enrollment and prescription form, reimbursement forms, NDC codes, and additional support for your SKYRIZI® (risankizumab-rzaa) dermatology patients.
SKYRIZI® (risankizumab-rzaa) is a prescription medicine used to treat adults: • with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment
When faxing this form, please include the patient demographic sheet, ensuring the following patient information is included: full home address, email address, medical and prescription insurance information, and any relevant clinical details.
The categories of personal information collected in this Enrollment and Prescription Form include contact, insurance, prescription, and medical history information. The personal information collected will be used to provide and manage the Skyrizi Complete program and to perform research and analytics on a de-identified basis.
Access & Support - SKYRIZI® (risankizumab-rzaa) for Crohn's
Committed to AbbVie's legacy of reliable access and support for your SKYRIZI® patients. Learn about Skyrizi Complete. See Important Safety, Prescribing Info.
SKYRIZI® (risankizumab-rzaa) HCP - Official Site by AbbVie Inc.
A biologic treatment for adult patients living with moderate to severe Plaque Psoriasis, adults with active Psoriatic Arthritis, adults with moderate to severe active Crohn's Disease, and adults with moderate to severe Ulcerative Colitis. See SKYRIZI® (risankizumab-rzaa) Important Safety Information for risks & safety details.
This form details the options for reimbursement claim submission for eligible, commercially insured SKYRIZI patients with Crohn’s disease or ulcerative colitis who are enrolled in Skyrizi Complete.
Patient & Practice Resources | SKYRIZI® (risankizumab-rzaa)
SKYRIZI COMPLETE ENROLLMENT AND PRESCRIPTION FORM. Download and fill out the Skyrizi Complete Enrollment and Prescription Form with your patient. After submitting the form, your patient will receive a call from a Nurse Ambassador* within one business day. The call may come from any area code.
Skyrizi Complete - SKYRIZI® (risankizumab-rzaa) for UC
INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR SKYRIZI ® (risankizumab-rzaa) 1. Indications. Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
You may obtain the PA form through one of the following: • Health plan’s website • CoverMyMeds ® • Specialty Pharmacy • Field Access Specialist Ensure you document the following in your PA submission and chart notes (as applicable):